Association of Celiac Disease With Pembrolizumab
Author:
Publisher
Cureus, Inc.
Subject
Aerospace Engineering
Reference15 articles.
1. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid O;N Engl J Med,2013
2. Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanoma;Chan MM;J Immunother,2015
3. Safety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melanoma;Weber JS;J Clin Oncol,2017
4. Management of immune-related adverse events and kinetics of response with ipilimumab;Weber JS;J Clin Oncol,2012
5. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab;Topalian SL;J Clin Oncol,2014
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Subclinical Celiac Disease Unmasked by Immune Checkpoint Inhibitor Therapy;Journal of Immunotherapy;2023-02-13
2. Small bowel villous atrophy due to immune-checkpoint inhibitors: report of two cases and literature review;Drugs in Context;2022-10-21
3. Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint Therapy;Frontiers in Immunology;2022-04-14
4. Checkpoint Inhibitors and Induction of Celiac Disease-like Condition;Biomedicines;2022-03-04
5. Histological Features of Celiac-Disease-like Conditions Related to Immune Checkpoint Inhibitors Therapy: A Signal to Keep in Mind for Pathologists;Diagnostics;2022-02-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3